Prashant Kapoor

77PUBLICATIONS
157CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Jul 21, 2026
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.

|Jul 18, 2026
Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma.

|Jun 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

|Apr 22, 2026
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myeloma.

Pageof 13

Frequent Collaborators

65 joint publications

Shaji Kumar

57 joint publications

Angela Dispenzieri

57 joint publications

Taxiarchis V Kourelis

54 joint publications

Morie Gertz